Treatment Patterns and Effectiveness and Safety of Anticoagulant Therapy

Moderator(s)

• 

  Tianze Jiao, PhD (he/him/his)

  Assistant Professor
  University of Florida College of Pharmacy, United States
• 

  Fawaz Alharbi, MSc, PhD

  Director of Drug Safety and Risk management
  Saudi Food and Drug Authority , Saudi Arabia

Presentations:

• 1:30 PM – 1:45 PM CEST

  Comparative bleeding risks among NOAC users for nonvalvular atrial fibrillation aged <65 years in the Sentinel System
  

  Presenting Author: Marie C. Bradley, PhD, MPharm, MSc.PH – Real World Evidence Analytics, Office of Medical Policy, CDER, US FDA

  Co-Author: Andrew L. Simon, MS – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA

  Co-Author: Joy Kolonoski – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA

  Co-Author: David J. Graham, MD, MPH – US Food and Drug Administration

  Co-Author: Rongmei zhang, PhD – Office of Biostatistics, Center for Drug Evaluation and Research, US FDA

  Co-Author: John G. Connolly – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA
• 1:45 PM – 2:00 PM CEST

  Comparative effectiveness and safety of dual antiplatelet therapy with ticagrelor vs. clopidogrel in older adults with acute coronary syndrome: A population-based study using the target trial framework.
  

  Presenting Author: Carole Anna Marxer, PhD – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet

  Co-Author: Paul Hjemdahl – Department Medicine Solna, Clinical Epidemiology/Clinical Pharmacology, Karolinska Institutet and Karolinska University Hospital

  Co-Author: Tomas Jernberg – Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet

  Co-Author: Juan J. Carrero – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet

  Co-Author: Edouard L. Fu – Leiden University Medical Center
• 2:00 PM – 2:15 PM CEST

  Switching from warfarin to direct oral anticoagulants in older adults with atrial fibrillation: a US nationwide cohort study
  

  Presenting Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School

  Co-Author: Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA

  Co-Author: Darae Ko – Hebrew Rehabilitation Center, Harvard Medical School

  Co-Author: Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School

  Co-Author: Alexander Cervone – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School

  Co-Author: Julianna Mastrorilli – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School

  Co-Author: Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research
• 2:15 PM – 2:30 PM CEST

  Comparative effectiveness and safety of extended treatment vs. discontinuation of oral anticoagulants in patients with venous thromboembolism
  

  Presenting Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School

  Co-Author: Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research

  Co-Author: Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA

  Co-Author: Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School

  Co-Author: Alexander Cervone – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School

  Co-Author: Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
• 2:30 PM – 2:45 PM CEST

  Withholding of oral anticoagulants in patients with dementia and atrial fibrillation by frailty status
  

  Presenting Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School

  Co-Author: Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA

  Co-Author: Darae Ko – Hebrew Rehabilitation Center, Harvard Medical School

  Co-Author: Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School

  Co-Author: Alexander Cervone – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School

  Co-Author: Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research
• 2:45 PM – 3:00 PM CEST

  Effectiveness and Safety of Oral Anticoagulants among patients with Atrial Fibrillation and Advanced Kidney Disease
  

  Co-Author: Qiaoxi Chen, phD – Brigham and Women's Hospital

  Co-Author: Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA

  Co-Author: Edouard L. Fu – Leiden University Medical Center

  Co-Author: Chun-Ting Yang, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School

  Presenting Author: Kevin Pritchard, OT, PhD, OTR – Brigham and Women's Hospital

  Co-Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

  Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School